Artemis Medicare Services Limited
Artemis Medicare Services Limited engages in the management and operation of multi-specialty hospitals in India and internationally. The company provides medical and surgical intervention, and inpatient and outpatient services. It also offers billing and insurance, childcare, emotional and support program, full body checkup, international patient, medical interpreter and record, mind body medicine, nursing, nutrition, patient and family advisory, patient advocacy and portal, pre-admission testing, and smoking cessation program services, as well as home care services. Artemis Medicare Services Limited was incorporated in 2004 and is based in Gurugram, India.
Valuation
Profitability
Returns
Solvency
AI Summary
Indian StockStrengths1
- Strong 5-year net profit CAGR of 19.6%
Concerns0
Rule-based from financial data. Not advice.
Monthly Returns
Year-to-Date ROI
Historical Volatility
Historical Performance
Revenue, profitability, and cash flow trends (βΉ Crores)
Revenue (10Y)
Operating Income (10Y)
Net Profit (10Y)
Operating Margin % (10Y)
Dividend Payout % (10Y)
Free Cash Flow (10Y)
Growth Summary
Latest fiscal year: Mar 2025
Historical Growth
Year-by-year revenue, profitability, and cash flow (βΉ Crores, last 10 years)
| Year | Revenue | Op. Income | Net Profit | CFO | FCF | ROE | Rev Growth 1Y | NP Growth 1Y |
|---|---|---|---|---|---|---|---|---|
| Mar 2025 | βΉ913.00 Cr | β | βΉ83.00 Cr | β | β | 9.9% | 8.0% | 69.4% |
| Mar 2024 | βΉ845.00 Cr | β | βΉ49.00 Cr | β | β | 10.8% | 18.3% | 22.5% |
| Mar 2023 | βΉ714.00 Cr | β | βΉ40.00 Cr | β | β | 9.9% | 31.0% | 21.2% |
| Mar 2022 | βΉ545.00 Cr | β | βΉ33.00 Cr | β | β | 9.1% | 35.6% | 371.4% |
| Mar 2021 | βΉ402.00 Cr | β | βΉ7.00 Cr | β | β | 2.2% | -28.6% | -65.0% |
| Mar 2020 | βΉ563.00 Cr | β | βΉ20.00 Cr | β | β | 6.4% | 2.9% | -4.8% |
| Mar 2019 | βΉ547.00 Cr | β | βΉ21.00 Cr | β | β | 7.5% | 8.7% | -22.2% |
| Mar 2018 | βΉ503.00 Cr | β | βΉ27.00 Cr | β | β | 11.7% | 9.6% | 0.0% |
| Mar 2017 | βΉ459.00 Cr | β | βΉ27.00 Cr | β | β | 13.2% | 14.2% | 22.7% |
| Mar 2016 | βΉ402.00 Cr | β | βΉ22.00 Cr | β | β | 12.0% | 9.2% | 15.8% |
Financial Statements
Income statement, balance sheet, and cash flow (βΉ Crores, as reported)
Consolidated Figures in USD Millions.
| Unnamed: 0 | TTM |
|---|---|
| Revenue / Net Sales | 981 |
| Total Expenses | 818 |
| EBIT / Operating Profit | 163 |
| OPM % | 17% |
| Other Income | 36 |
| Finance Costs | 29 |
| Depreciation & Amortisation | 44 |
| Profit Before Tax | 126 |
| Tax % | - |
| Net Profit / PAT | 95 |
| EPS (βΉ) | 6.90 |
| Dividend Payout % | - |
Peer Comparison
Healthcare sector peers, ranked by market cap
| Company | Market Cap | Revenue | P/E | P/B | EV/EBITDA | Rev G 1Y |
|---|---|---|---|---|---|---|
| Artemis Medicare Services Limitedthis co. | βΉ4.06 K Cr | βΉ913.00 Cr | 42.60 | 4.01 | 32.03 | 8.0% |
| Sun Pharmaceutical Industries Ltd. | βΉ4.15 L Cr | βΉ23.00 K Cr | 88.70 | 17.43 | 72.30 | 13.5% |
| Divi's Laboratories Ltd. | βΉ1.71 L Cr | βΉ9.20 K Cr | 67.90 | 11.13 | 67.21 | 20.0% |
| Torrent Pharmaceuticals Ltd. | βΉ1.33 L Cr | βΉ9.68 K Cr | 62.50 | 15.76 | 45.64 | 13.5% |
| Cipla Ltd. | βΉ1.17 L Cr | βΉ19.05 K Cr | 22.50 | 3.51 | 19.33 | 14.9% |
| Apollo Hospitals Enterprises Ltd. | βΉ1.05 L Cr | βΉ8.20 K Cr | 75.00 | 11.28 | 54.44 | 12.8% |
| Max Healthcare Institute Limited | βΉ1.00 L Cr | βΉ2.66 K Cr | 144.00 | 11.76 | 96.84 | 13.8% |
| Industry Average | β | βΉ3.29 K Cr | 98.63 | 8.11 | 65.50 | 20.2% |